China's CanSino in mRNA vaccine deal with AstraZeneca
Published
CanSino Biologics has agreed with AstraZeneca to provide "contract development and manufacturing services" to support the Anglo-Swedish drugmaker's messenger RNA (mRNA) vaccine programme, the Chinese company said on Tuesday. In a filing to Shanghai's stock exchange, CanSino said it would…
#cansinobiologics #astrazeneca #anglo #messengerrna #shanghai #cansino #cs2034 #communistparty #commerce #wangwentao